000 01256nam##2200289za#4500
0019.694603
003CaOODSP
00520210624234208
007cr |||||||||||
008150407|2010||||xxc|||||o    f|0| 0 eng|d
020 |a978-1-897463-84-0
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH174-21/2010E-PDF
1101 |aCanada.|bHealth Council of Canada.
24510|aKeeping an eye on prescription drugs, keeping Canadians safe : |h[electronic resource]|bactive monitoring systems for drug safety and effectiveness in Canada and internationally / |cby Mary E. Wiktorowicz ... [et al.].
260 |aToronto - Ontario : |bHealth Council of Canada |cNovember 2010.
300 |a50p.|bfigs. (some coloured), glossary, references, tables
590 |a11-20|b2011-05-20
69007|aHealth|2gcpds
69007|aPrescription drugs|2gcpds
69007|aAssessment|2gcpds
69007|aPharmaceutical industry|2gcpds
69007|aPublic safety|2gcpds
7201 |aWiktorowicz, Mary E.
77508|tSurveiller les médicaments d'ordonnance, veiller à la sécurité des canadiens : |w(CaOODSP)9.638780
85640|ahttp://publications.gc.ca|qPDF|s821 KB|uhttps://publications.gc.ca/collections/collection_2011/ccs-hcc/H174-21-2010-eng.pdf